STRATA Skin Sciences (SSKN) Debt to Equity (2013 - 2025)

STRATA Skin Sciences has disclosed Debt to Equity across 13 years of filings, most recently posting $5.28 for Q4 2025.

• Debt to Equity for Q4 2025 came in at $5.28, up 72.74% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.28 (up 72.74% YoY), and the FY2025 annual result was $5.28, up 72.74% from the prior year.
• Debt to Equity came in at $5.28 for Q4 2025 at STRATA Skin Sciences, down from $11.65 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $28.7 in Q2 2025 to a low of $0.02 in Q2 2021.
• The 5-year median for Debt to Equity is $0.91 (2023), against an average of $3.2.
• Across the five-year window, Debt to Equity tumbled 79.47% in 2021 and jumped 1705.29% in 2025, its largest moves.
• STRATA Skin Sciences' Debt to Equity stood at $0.29 in 2021, then gained by 18.91% to $0.34 in 2022, then surged by 246.24% to $1.19 in 2023, then surged by 157.7% to $3.06 in 2024, then jumped by 72.74% to $5.28 in 2025.
• The last three Debt to Equity figures came in at $5.28 (Q4 2025), $11.65 (Q3 2025), and $28.7 (Q2 2025), per Business Quant data.